CBDMD INC

YCBDNYSE AMERICAN

🏆 #3855 by market capEarnings Aug 19US Equity

$207.84▲ $2.27 (+1.09%)

Simulated price

1h—

24h▲ 1.1%

7d—

14d—

30d—

1y—

🏦Market Cap

$5M

Small Cap

📈Revenue Growth (YoY)

+2.0%

Slowing

📊Gross Margin

59.4%

Healthy

💵FCF Margin

—

⚖️P/S Ratio

0.3x

Cheap

Otter Score

Weak

No chart data available for YCBD.

Trading Snapshot

Day Range: $205.77 – $210.34
52-Week Range: $0.47 – $2.56
Volume: $2.44B
Avg Volume: $2.47B
Shares Outstanding: 10.5M
Next Earnings: Sep 29, 2026

Fundamentals Snapshot

Annual Revenue: $19M
Last Q Revenue: $6M
P/E Ratio: —
P/S Ratio: 0.3x
EPS (TTM): $-0.34
Dividend Yield: 0.00%

Why Investors Own YCBD

✓High-growth profile — revenue up +42.8% YoY with expanding US Equity exposure.
✓Healthy economics — 76% gross margin and 20% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$19M▲ +44.5% YoY

Gross Margin (TTM)

76.2%▲ +2.0% YoY

Operating Income (TTM)

$4M▲ +44.5% YoY

Free Cash Flow (TTM)

$4M▲ +44.5% YoY

About CBDMD INC

cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.

🦦